The aryl hydrocarbon receptor in tumor immunity
The aryl hydrocarbon receptor (AHR) binds environmental toxins and mediates immune regulation. The tryptophan metabolite kynurenine has now been identified as an endogenous ligand of the human AHR constitutively produced by gliomas and other types of cancer via tryptophan-2,3-dioxygenase (TDO), ther...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
01 May 2012
|
| In: |
OncoImmunology
Year: 2012, Jahrgang: 1, Heft: 3, Pages: 396-397 |
| ISSN: | 2162-402X |
| DOI: | 10.4161/onci.19071 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.4161/onci.19071 Verlag, Volltext: https://doi.org/10.4161/onci.19071 
|
| Verfasserangaben: | Michael Platten, Ulrike Litzenburger & Wolfgang Wick |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572588616 | ||
| 003 | DE-627 | ||
| 005 | 20220814131250.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180503s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4161/onci.19071 |2 doi | |
| 035 | |a (DE-627)1572588616 | ||
| 035 | |a (DE-576)502588616 | ||
| 035 | |a (DE-599)BSZ502588616 | ||
| 035 | |a (OCoLC)1341008123 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 245 | 1 | 4 | |a The aryl hydrocarbon receptor in tumor immunity |c Michael Platten, Ulrike Litzenburger & Wolfgang Wick |
| 264 | 1 | |c 01 May 2012 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.05.2018 | ||
| 520 | |a The aryl hydrocarbon receptor (AHR) binds environmental toxins and mediates immune regulation. The tryptophan metabolite kynurenine has now been identified as an endogenous ligand of the human AHR constitutively produced by gliomas and other types of cancer via tryptophan-2,3-dioxygenase (TDO), thereby suppressing antitumor immune responses via the AHR. Thus, this pathway represents an important novel target for cancer immunotherapy. | ||
| 650 | 4 | |a AHR | |
| 650 | 4 | |a glioma | |
| 650 | 4 | |a IDO | |
| 650 | 4 | |a tumor immunity | |
| 650 | 4 | |a typtophan catabolism | |
| 700 | 1 | |a Litzenburger, Ulrike |e VerfasserIn |0 (DE-588)1030343454 |0 (DE-627)735097054 |0 (DE-576)378142003 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 1(2012), 3, Seite 396-397 |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a The aryl hydrocarbon receptor in tumor immunity |
| 773 | 1 | 8 | |g volume:1 |g year:2012 |g number:3 |g pages:396-397 |g extent:2 |a The aryl hydrocarbon receptor in tumor immunity |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4161/onci.19071 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.4161/onci.19071 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180503 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 3 |y j | ||
| 998 | |g 1030343454 |a Litzenburger, Ulrike |m 1030343454:Litzenburger, Ulrike |p 2 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 910000 |d 911100 |e 910000PP121627780 |e 911100PP121627780 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1572588616 |e 3007838789 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1572588616","physDesc":[{"extent":"2 S."}],"origin":[{"dateIssuedDisp":"01 May 2012","dateIssuedKey":"2012"}],"person":[{"family":"Platten","given":"Michael","role":"aut","display":"Platten, Michael"},{"display":"Litzenburger, Ulrike","family":"Litzenburger","role":"aut","given":"Ulrike"},{"given":"Wolfgang","role":"aut","family":"Wick","display":"Wick, Wolfgang"}],"relHost":[{"disp":"The aryl hydrocarbon receptor in tumor immunityOncoImmunology","recId":"683365428","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"note":["Gesehen am 13.12.2022"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisher":"Taylor & Franics ; Landes Bioscience"}],"part":{"volume":"1","year":"2012","issue":"3","text":"1(2012), 3, Seite 396-397","extent":"2","pages":"396-397"},"id":{"zdb":["2645309-5"],"issn":["2162-402X"],"eki":["683365428"]},"titleAlt":[{"title":"Onco Immunology"}],"pubHistory":["1.2012 -"]}],"title":[{"title_sort":"aryl hydrocarbon receptor in tumor immunity","title":"The aryl hydrocarbon receptor in tumor immunity"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 03.05.2018"],"name":{"displayForm":["Michael Platten, Ulrike Litzenburger & Wolfgang Wick"]},"id":{"eki":["1572588616"],"doi":["10.4161/onci.19071"]}} | ||
| SRT | |a PLATTENMICARYLHYDROC0120 | ||